Recall of FICIN PANEL TWO SYSTEM (11 UNTREATED CELL SUSPENSIONS AND 11 FICIN-TREATED)

According to Health Canada (via FOI), this recall involved a device in Canada that was produced by IMMUCOR INC..

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Event ID
    18344
  • Event Risk Class
    II
  • Event Initiated Date
    2002-08-13
  • Event Country
  • Event Source
    HC
  • Notes / Alerts
    Canadian data is current through March 2018. All of the data comes from Health Canada, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Canada.
  • Extra notes in the data
  • Reason
    Loss of enzyme activity. these products maynot contain adequate enzyme activity for treatment of rec cells throughout the expiration dating of the product.

Device

  • Model / Serial
    Model Catalog: (Lot serial: 212827 312878409928507979); Model Catalog: (Lot serial: LIC# 13482 CAT # 2310); Model Catalog: (Lot serial: SAME AS PREVIOUS); Model Catalog: (Lot serial: LOT EF50-1 LIC#13477CAT#7056); Model Catalog: (Lot serial: 122802205814219853); Model Catalog: (Lot serial: 305866319903402916); Model Catalog: (Lot serial: 416954430966); Model Catalog: (Lot serial: lic#13482); Model Catalog: (Lot serial: 514004)
  • Product Description
    FICIN PANEL TWO
  • Manufacturer

Manufacturer

  • Manufacturer Address
    HOUSTON
  • Manufacturer Parent Company (2017)
  • Source
    HC